[PAR] QoQ Quarter Result on 31-Dec-2016 [#Q2]

Stock
[PAR] Paradigm Biopharmaceuticals Limited
Announcement Date
30-Dec-2016
Financial Year
2017
Quarter
31-Dec-2016 [#Q2]
Profit Trend
QoQ- -87.62%
YoY- -98.03%
Quarter Report
PAR's Result
PAR's Financial Summary
View:
Show?
Quarter Result
30/06/18 31/12/17 30/06/17 31/12/16 30/06/16 31/12/15 30/06/15 CAGR
Revenue 2,660 22 1,766 58 1,244 46 0 -
PBT -2,617 -3,573 -1,457 -2,818 -1,502 -1,423 -960 39.65%
Tax 0 0 0 0 0 0 2 -
NP -2,617 -3,573 -1,457 -2,818 -1,502 -1,423 -960 39.65%
Tax Rate - - - - - - - -
Total Cost 5,277 3,596 3,223 2,876 2,746 1,469 960 76.39%
Ratio Analysis
30/06/18 31/12/17 30/06/17 31/12/16 30/06/16 31/12/15 30/06/15 CAGR
NP Margin -98.38 -15,998.41 -82.52 -4,891.80 -120.68 -3,086.06 0.00 -
Per Share
30/06/18 31/12/17 30/06/17 31/12/16 30/06/16 31/12/15 30/06/15 CAGR
EPS -0.02 -0.03 -0.01 -0.03 -0.02 -0.02 -0.02 0.00%
EPS Diluted -0.02 -0.03 -0.01 -0.03 -0.02 -0.02 -0.02 0.00%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.